These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 12181031)
21. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Koczwara B; Spangenthal E; Bernstein SH Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907 [TBL] [Abstract][Full Text] [Related]
23. Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission. Girardi K; Paviglianiti A; Cirillo M; Bianchi A; Gherardi G; Annibali O; Cerchiara E; Marchesi F; Tomarchio V; Miglio C; Tirindelli M; Onetti Muda A; Avvisati G J Clin Exp Hematop; 2012; 52(1):31-4. PubMed ID: 22706528 [TBL] [Abstract][Full Text] [Related]
24. Criteria for use of cladribine in adults. Fedak MN Am J Hosp Pharm; 1994 Sep; 51(17):2185-6. PubMed ID: 7985700 [No Abstract] [Full Text] [Related]
31. Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature. Broccoli A; Gandolfi L; Pellegrini C; Agostinelli C; Argnani L; Zinzani PL Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 27002952 [TBL] [Abstract][Full Text] [Related]
32. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia. Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414 [No Abstract] [Full Text] [Related]
33. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine). Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889 [TBL] [Abstract][Full Text] [Related]
34. High incidence of skin rash in patients with hairy cell leukemia treated with cladribine. Ganzel C; Gatt ME; Maly A; Ben-Yehuda D; Goldschmidt N Leuk Lymphoma; 2012 Jun; 53(6):1169-73. PubMed ID: 22035415 [TBL] [Abstract][Full Text] [Related]
35. Bladder stones formation eight months after treatment of hairy-cell leukemia with 2-chloro-deoxyadenosine: a case report. Bessa O Conn Med; 1995 Jun; 59(6):331. PubMed ID: 7648851 [No Abstract] [Full Text] [Related]
36. Transient eosinophilia in a patient with hairy-cell leukaemia treated with 2-chlorodeoxyadenosine. Robak T; Błasińska-Morawiec M; Krykowski E Acta Haematol Pol; 1992; 23(4):285-90. PubMed ID: 1363455 [TBL] [Abstract][Full Text] [Related]
37. Treatment of hairy cell leukaemia (HCL) with 2-chlorodeoxyadenosine (2-CdA): identification of parameters predictive of adverse effects. Legrand O; Vekhoff A; Marie JP; Zittoun R; Delmer A Br J Haematol; 1997 Oct; 99(1):165-7. PubMed ID: 9359518 [TBL] [Abstract][Full Text] [Related]
38. Ocular manifestation of hairy cell leukemia with dramatic response to 2-chloro-deoxy-adenosine. Robinson A; Eting E; Zeidman A; Djaldetti M; Mittelman M; Savir H Am J Ophthalmol; 1996 Jan; 121(1):97-9. PubMed ID: 8554090 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of one hairy cell leukemia case with single course of cladribine]. Zhang LJ; Qiu HX; Li JY Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):336. PubMed ID: 21729604 [No Abstract] [Full Text] [Related]
40. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia. Yang MH; Ho CH Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]